• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
AC8
Click for more information
0.00% 4.0¢

AUSCANN GROUP HOLDINGS LTD - Charts / Financials

Market Cap $17.62M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare

AusCann Group Holdings Limited is an Australia-based company focused on the development... AusCann Group Holdings Limited is an Australia-based company focused on the development and commercialization of cannabinoid-derived therapeutic products to address unmet needs for humans and animals within Australia and internationally. Its products include Neuvis, CPAT-01, DermaCann and MicroMax. CPAT-01 is a liquid, oral veterinary medicine containing standardized tetrahydrocannabinol (THC) and cannabinoids (CBD) whole plant extracts in a proprietary ratio to target pain and inflammation in dogs. DermaCann is a CBD-derived nutraceutical in development for healthy skin and immune function in dogs with dermatological conditions. The product is a liquid oral oil formulation containing CBD in a patented combination with other bioactive lipids designed to target inflammation and immune modulation pathways. MicroMAX is an encapsulation technology for use in the field of animal therapeutics. Its subsidiaries include AusCann Operations Pty Ltd and CannPal Animal Therapeutics Limited.More

refresh Created with Sketch. REFRESH
Last update - 15.59pm 03/05/2024 (20 minute delay) ?
Day
Open 0.0¢   Day High 0.0¢   Day Low 0.0¢
Daily Volume 0
Bids   Sellers
Number Price Volume   Number Price Volume
0 0.0¢ 0   0 0.0¢ 0

Directors & Senior Management

Mr. Christopher Mews Chief Financial Officer
Ms. Margaret Curtis Head of Research and Development
Mrs. Rachel Kerr Company Secretary
Mr. Andrew Chapman Non-Executive Chairman of the Board
Mr. Robert Clifford Non-Executive Independent Director
Mr. Brett Anthony Mitchell Non-Executive Independent Director

Data source: Refinitiv

(20min delay)
Last
4.0¢ 		Change
0.000(0.00%) 		Mkt cap ! $17.62M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Top Stories

Why Princeton Professor rates BlinkLab's autism & ADHD screening app

In this interview with Sonia Madigan, Professor Sam Wang of Princeton University discusses the development and potential of BlinkLab's (ASX:BB1) AI-driven smartphone app, designed to screen for autism and ADHD.
Lithium Universe ends the quarter charged up for Quebec Refinery roll-out Lithium Universe has closed off the March quarter with a new Chief Financial Officer and strategically located land anchored for its lithium refinery in Quebec, Canada.
Infini Resources gearing up for UAV geophys survey over Portland Creek Infini Resources has announced its execution of an application for UAV-based geophysical surveys over its Portland Creek Uranium Project.
Macquarie profits fall 32% on 'market volatility' and low-achieving 'green investments' Macquarie Group Ltd (ASX:MQG) has shaved more than 30 percent off its net profit in the final quarter of the 2024 financial year (FY 2024), compared to the same time last year, with executives speaking cautiously about market volatility and @lower asset realisations’ from green in...
Dancing to that same 70s tune, China, and why I'm backing gold It is too early to judge what concrete measures the Future Made in Australia policy will entail. However, any policy which has a stated aim to screen qualifying capital for suitability at a government level, does not seem like a strong signal for foreigners to get on a plane, come visit some mine sites and invest.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.